MMFA
Main Management Fund Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-598,200
| Closed | -$55.5M | – | 7 |
|
|
2024
Q2 | $55.5M | Buy |
598,200
+45,700
| +8% | +$4.24M | 9.99% | 4 |
|
|
2024
Q1 | $52.4M | Buy |
552,500
+81,000
| +17% | +$7.69M | 10.66% | 3 |
|
|
2023
Q4 | $42.1M | Buy |
471,500
+190,500
| +68% | +$17M | 11.79% | 2 |
|
|
2023
Q3 | $20.5M | Buy |
281,000
+37,500
| +15% | +$2.74M | 5.97% | 7 |
|
|
2023
Q2 | $20.3M | Buy |
243,500
+45,200
| +23% | +$3.76M | 6.53% | 7 |
|
|
2023
Q1 | $15.1M | Buy |
198,300
+28,300
| +17% | +$2.16M | 6.59% | 7 |
|
|
2022
Q4 | $14.1M | Buy |
170,000
+10,600
| +7% | +$880K | 8.9% | 7 |
|
|
2022
Q3 | $12.6M | Buy |
159,400
+10,500
| +7% | +$833K | 9.08% | 5 |
|
|
2022
Q2 | $11.1M | Buy |
148,900
+83,500
| +128% | +$6.2M | 7.82% | 5 |
|
|
2022
Q1 | $5.88M | Buy |
+65,400
| New | +$5.88M | 3.8% | 7 |
|